As a key oncogentic signaling pathway, PI3K/AKT pathway plays a pivotal role in various cancers, including breast cancer [34], colorectal cancer [35], hepatocellular carcinoma [36] and chronic lymphocytic leukemia [37]. This evidence concerns the gene AKT1 and breast carcinoma.